3 papers and 0 clinical trials exploring ayahuasca as a treatment for eating disorders.
Ayahuasca is a botanical decoction combining DMT with MAO-inhibiting harmala alkaloids, producing intense psychedelic effects lasting 3-6 hours. Clinical trials show rapid, large antidepressant effects from a single dose, with a favourable safety profile in controlled settings.
Full Ayahuasca profileEating disorders, including anorexia nervosa and bulimia nervosa, affect approximately 16 million individuals globally. The exploration of psychedelics, such as psilocybin and MDMA, as potential treatments for these conditions is a burgeoning field of research, showing promise in alleviating symptoms and improving quality of life.
Full Eating Disorders profileNo clinical trials have been tagged with both Ayahuasca and Eating Disorders yet.
Trials are continuously being added as new studies are registered.